We have observed
4 EP applications
Jane Helen Wainwright
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME
USE OF ANTIBODIES AGAINST ICAM-1 IN THE TREATMENT OF PATIENTS WITH RELAPSED CANCER
OXIDIZED GLUTATHIONE ASSAY
LOW-PRESSURE ENVIRONMENT FOR FLUID TRANSFER DEVICES